Conventional radiotherapy and intensity-modulated radiotherapy in carcinoma vulva: An experience from a tertiary medical center of India

被引:10
作者
Mazumder, Koustav [1 ]
Elangovan, Arun [1 ]
Rai, Bhavana [1 ]
Suri, Vanita [2 ]
Jain, Vanita [2 ]
Kalra, Jaswinder [2 ]
Ghoshal, Sushmita [1 ]
机构
[1] Postgrad Med Educ & Res, Dept Radiotherapy & Oncol, Chandigarh, India
[2] Postgrad Med Educ & Res, Dept Gynecol & Obstet, Chandigarh, India
关键词
Radiotherapy; cancer; vulva; DOSIMETRIC EVALUATION; CANCER;
D O I
10.4103/sajc.sajc_66_17
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Context: Vulvar cancer is one of the uncommon gynecological malignancies. Multimodality treatment with surgery, radiotherapy, and chemotherapy are required for treatment of the disease. Aims: The aim of the study was to evaluate clinical outcome in patients of carcinoma vulva, treated at our institution. Subjects and Methods: This was a retrospective-cohort study done in 50 patients with squamous cell carcinoma of the vulva, treated at our institution from January 2008 to December 2014. Data were analyzed on the basis of age, stage, type of treatment received, and treatment-related toxicity. Disease-free survival and overall survival were estimated. Statistical Analysis Used: Kaplan-Meier survival analysis and Chi-square test were used for statistical analysis. Results: Majority of the patients (52%) had presented with Stage III disease. Thirty-six of 50 patients underwent surgery: simple vulvectomy - 2, radical vulvectomy - 34, bilateral inguinal lymph node dissection was done in 32 patients, and 1 patient underwent ipsilateral-inguinal lymph node dissection. Among 40 patients who received radiotherapy and eight patients received palliative radiotherapy. Seventeen patients underwent intensity-modulated radiotherapy (IMRT) and 15 patients received conventional radiotherapy. Significantly less Grade 2 or more skin toxicity (P = 0.003) observed in patients who underwent IMRT. Among non-IMRT group, eight patients required treatment break during radiation. At a median follow-up time of 25.5 months, median overall survival was 31 months and median disease-free survival was 25 months. About 42% patients were alive and free of disease at last follow-up. Conclusions: Modified radical vulvectomy with inguinal lymph node dissection followed by radiotherapy is the mainstay of management of locally advanced carcinoma vulva. Using IMRT, we could minimize the treatment related radiation toxicity and treatment breaks.
引用
收藏
页码:41 / 43
页数:3
相关论文
共 50 条
[31]   Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy [J].
Wu, Shixiu ;
Xia, Bing ;
Han, Fei ;
Xie, Ruifei ;
Song, Tao ;
Lu, Lixia ;
Yu, Wei ;
Deng, Xiaowu ;
He, Qiancheng ;
Zhao, Cong ;
Xie, Conghua .
PLOS ONE, 2015, 10 (08)
[32]   Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma [J].
Tu, Lingli ;
Sun, Lan ;
Xu, Yong ;
Wang, Yongsheng ;
Zhou, Lin ;
Liu, Yongmei ;
Zhu, Jiang ;
Peng, Feng ;
Wei, Yuquan ;
Gong, Youling .
RADIATION ONCOLOGY, 2013, 8
[33]   Application of intensity-modulated radiotherapy in unresectable poorly differentiated thyroid carcinoma [J].
Xue, Fen ;
Li, Duanshu ;
Hu, Chaosu ;
Wang, Zhuoying ;
He, Xiayun ;
Wu, Yi .
ONCOTARGET, 2017, 8 (09) :15934-15942
[34]   Nasopharyngeal carcinoma: Experience and treatment outcome with radical conformal radiotherapy from a tertiary care center in India [J].
Kunheri, Beena ;
Agarwal, Gunjan ;
Sunil, P. S. ;
Nair, Anoop Ramesan ;
Pushpaja, K. U. .
INDIAN JOURNAL OF CANCER, 2017, 54 (03) :502-507
[35]   Is intensity-modulated radiotherapy superior to conventional techniques to prevent late ear complications of nasopharyngeal cancer? [J].
Ayca Ant ;
Ömer Yazici ;
Pinar Atabey ;
Ferit Ferhat Aslan ;
Arzubetul Duran ;
Samet Ozlugedik ;
Yusuf Kemal Kemaloglu .
European Archives of Oto-Rhino-Laryngology, 2019, 276 :977-984
[36]   Is intensity-modulated radiotherapy superior to conventional techniques to prevent late ear complications of nasopharyngeal cancer? [J].
Ant, Ayca ;
Yazici, Omer ;
Atabey, Pinar ;
Aslan, Ferit Ferhat ;
Duran, Arzubetul ;
Ozlugedik, Samet ;
Kemaloglu, Yusuf Kemal .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2019, 276 (04) :977-984
[37]   Progress with Intensity-modulated Radiotherapy Implementation in the UK [J].
Mayles, W. P. M. ;
Cooper, T. ;
Mackay, R. ;
Staffurth, J. ;
Williams, M. .
CLINICAL ONCOLOGY, 2012, 24 (08) :543-544
[38]   Salvage radiotherapy: A plea for dose-escalation with intensity-modulated radiotherapy [J].
Ost, Piet ;
Cozzarini, Cesare ;
Bossi, Alberto ;
De Meerleer, Gert .
EUROPEAN JOURNAL OF CANCER, 2012, 48 (09) :1415-1416
[39]   Cervix carcinomas: Place of intensity-modulated radiotherapy [J].
Barillot, I. .
CANCER RADIOTHERAPIE, 2009, 13 (6-7) :507-510
[40]   REIRRADIATION USING INTENSITY-MODULATED RADIOTHERAPY FOR RECURRENT NASOPHARYNGEAL CARCINOMA: A REPORT OF 10 CASE SERIES FROM A MOROCCAN CENTER [J].
Jaba, Siham ;
Agbanglanon, Patricia ;
Mosse, Wilfried Bassane Alain ;
Kietga, Gael ;
Elmajjaoui, Sanae ;
El Kacemi, Hanan ;
Kebdani, Tayeb ;
Benjaafar, Noureddine .
JOURNAL OF MEDICAL AND SURGICAL RESEARCH, 2021, 7 (03) :901-908